Brief: Tactile Medical Says First Patient Enrolled In Clinical Trial Testing Effectiveness Of Flexitouch Plus For Treatment Of Head And Neck Lymphedema
Sept 30 (Reuters) - Tactile Systems Technology Inc TCMD.O :
* TACTILE MEDICAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN
RANDOMIZED, CONTROLLED CLINICAL TRIAL EVALUATING THE
EFFECTIVENESS OF FLEXITOUCH® PLUS FOR THE TREATMENT OF HEAD AND
NECK LYMPHEDEMA
Source text for Eikon: ID:nGNX44GPpW
Further company coverage: TCMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tactile Systems Technology
See all newsTactile Systems Q1 revenue rises 23% on higher product sales
Brief: Tactile Systems Technology Q1 Revenue USD 75.3 Million Vs. IBES Estimate USD 70.6 Million
Brief: Tactile Medical Acquires Lymphatech For $6.8 Million Upfront
Tactile Systems beats Q4 revenue estimates on strong growth in lymphedema products
Brief: Tactile Systems Technology Q4 Revenue USD 103.6 Million Vs. IBES Estimate USD 93.8 Million